The Glucosamine Controversy; A Pharmacokinetic Issue
Glucosamine (GlcN) is a naturally occurring aminosugar that is widely used to treat osteoarthritis despite controversial clinical trial results. Animal studies, on the other hand, unequivocally suggest anti-inflammatory and disease modifying effects for GlcN. Many explanations have been offered as t...
Saved in:
Main Authors: | Ali Aghazadeh-Habashi (Author), Fakhreddin Jamali (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2011-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Impact of Implementation of the Canadian Regulatory Requirements on the Quality of Natural Health Products: The Glucosamine Case
by: Ali Aghazadeh-Habashi, et al.
Published: (2014) -
The Antiinflammatory Action and Pharmacokinetics of a Novel Glucosamine-based Di-Peptide Aminosugar
by: Mohammad H. Gilzad-Kohan, et al.
Published: (2013) -
Improved Sensitive High Performance Liquid Chromatography Assay for Glucosamine in Human and Rat Biological Samples with Fluorescence Detection
by: Fakhreddin Jamali, et al.
Published: (2010) -
Photoallergic Dermatitis To Glucosamine
by: Goel Ashima, et al.
Published: (2003) -
Explicative Cases of Controversial Issues in Neurosurgery
Published: (2012)